Sanofi traded at 99.37 this Tuesday June 28th, decreasing 0.22 or 0.22 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 1.05 percent. Over the last 12 months, its price rose by 12.50 percent. Looking ahead, we forecast Sanofi to be priced at 96.96 by the end of this quarter and at 86.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
99.37
Daily Change
-0.22%
Yearly
12.50%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.46 -0.68 -0.44% 35.76%
Aena 129.75 -0.95 -0.73% -6.49%
Alcon AG 66.44 -0.18 -0.27% 1.90%
Almirall SA 10.61 -0.16 -1.49% -28.55%
Amgen 243.51 -1.34 -0.55% 0.43%
Amarin 1.85 -0.07 -3.65% -58.71%
Artemis Alpha 304.00 9.00 3.05% -30.11%
AstraZeneca 10,786.00 -20.00 -0.19% 24.35%
Bayer 60.23 0.83 1.40% 16.66%
Biogen 202.51 -11.06 -5.18% -41.42%
BMW 76.48 0.75 0.99% -16.20%
Bristol-Myers Squibb 78.70 -1.28 -1.60% 18.76%
Daimler 58.93 -0.31 -0.52% -22.75%
Vinci 87.67 1.50 1.74% -3.16%
Essilor 144.30 1.00 0.70% -7.25%
Fresenius Medical Care 47.80 0.11 0.23% -31.32%
Fresenius 28.98 0.25 0.87% -34.13%
Genmab 2,242.00 -30.00 -1.32% -13.57%
Gilead Sciences 62.21 -0.62 -0.99% -8.42%
Galapagos 53.22 0.14 0.26% -10.51%
GRIFOLS 19.38 0.23 1.17% -14.59%
GlaxoSmithKline 1,766.00 1.80 0.10% 23.88%
Hikma Pharmaceutical 1,677.50 11.50 0.69% -31.33%
J&J 176.76 -5.36 -2.94% 7.76%
Eli Lilly 317.79 -9.48 -2.90% 38.55%
Lonza Group 511.60 -1.40 -0.27% -22.95%
Merck 163.70 -1.40 -0.85% 1.87%
Merck & Co 91.90 -2.51 -2.66% 19.03%
Novartis 81.14 -0.90 -1.10% -4.06%
Orion 39.71 0.33 0.84% 8.29%
Pfizer 50.67 -1.21 -2.33% 29.59%
Philips 20.66 -0.20 -0.94% -50.71%
Recordati 41.18 0.07 0.17% -14.95%
Regeneron Pharmaceuticals 594.42 -7.98 -1.32% 8.87%
Roche Holding 317.55 -5.00 -1.55% -8.96%
Sanofi 99.37 -0.22 -0.22% 12.50%
SAP 91.24 -1.06 -1.15% -23.80%
UCB 81.52 0.54 0.67% -8.01%
Volkswagen 140.82 1.94 1.40% -34.85%

Indexes Price Day Year
EU50 3549 10.41 0.29% -13.59%
FR40 6086 38.71 0.64% -7.33%
EU100 1173 8.29 0.71% -8.09%

Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.